27 results
Thumbnail

D2. 259 - A Comprehensive Decision Algorithm for Hypersensitivity Reactions to Iodinated Contrast Media in a Tertiary Care Setting

Thumbnail

D2.255 - NSAID Hypersensitivity Records: Assessing Documentation Practice, Challenges, and Areas for Improvement

Thumbnail

D2.256 - Cytokine release reaction after subcutaneous daratumumab

Thumbnail

D2.246 - Anaphylaxis to sugammadex in a 15 year-old-girl

Thumbnail

D2.247 - Sensitization to Meloxicam, Celecoxib and Paracetamol in patients intolerant to non-steroidal antiinflamatory drugs (NSAIDS)

Thumbnail

D2.248 - Allergy to quinolones: a clinical case

Thumbnail

D2.249 - Application of Desensitization Protocol with Rituximab in the Treatment of Corticosteroid-Dependent Nephrotic Syndrome in an Adolescent

Thumbnail

D2.250 - Can drug allergy develop in x-linked agammaglobulinemia (xla)? case report

Thumbnail

D2.251 - Anaphylaxis due to Andrographis panniculata - an emerging problem

Thumbnail

D2.252 - Confirmation of selectivity pattern to Non-Steroidal Anti-inflammatory Drugs: a retrospective study in a Central Hospital

Thumbnail

D2.253 - Is it possible to treat DRESS without systemic corticosteroids?

Thumbnail

D2.254 - Can a medication leave its mark on the skin?

Thumbnail

D2.257 - Anaphylaxis with FOLFOX scheme: not everything is Oxaliplatin

Thumbnail

D2.258 - Fixed drug eruption caused by co-amoxiclav

Thumbnail

D3.178 - Efficacy of Index of reactivity (IR) liquid sublingual immunotherapy in allergic rhinoconjunctivitis: A systematic review and meta-analysis of randomised studies

Thumbnail

D3.179 - Safety of 300IR liquid sublingual immunotherapy of cat allergen extract for respiratory allergy to cat dander: a post-marketing experience

Thumbnail

D3.180 - Good patient adherence to sublingual immunotherapy for allergic rhinitis can be achieved, when ENT-physicians collaborate with pharmacies in a straightforward adherence programme

Thumbnail

D3.182 - Health Economic Evaluation of 5-Grass Pollen Sublingual ImmunotherapyTablets for Grass Pollen-Induced Allergic Rhinitis in Finland, Norway and Sweden

Thumbnail

D3.183 - Reduction in Healthcare Resource Utilization in patients treated with 300 IR liquid SLIT: Real-World Evidence from Spain and Italy

Thumbnail

D3.184 - Treatment with the 300 IR house dust mite sublingual tablet is safe and well tolerated in adults and adolescents in a real-world data setting – results of a non-interventional post authorization safety study